Identification of Targets of JS-K Against HBV-Positive Human Hepatocellular Carcinoma Hepg2. 2.15 Cells with Itraq Proteomics

Total Page:16

File Type:pdf, Size:1020Kb

Identification of Targets of JS-K Against HBV-Positive Human Hepatocellular Carcinoma Hepg2. 2.15 Cells with Itraq Proteomics www.nature.com/scientificreports OPEN Identifcation of targets of JS‑K against HBV‑positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics Zhengyun Liu1,4, Yan Xu1,4, Wanling Zhang2, Xinghong Gao1, Guo Luo1, Hong Song2, Jie Liu3 & Huan Wang1,2* JS‑K, a nitric oxide‑releasing diazeniumdiolates, is efective against various tumors. We have discovered that JS‑K was efective against Hepatitis B virus (HBV)‑positive HepG2.2.15 cells. This study used iTRAQ to identify diferentially expressed proteins following JS‑K treatment of HepG2.2.15 cells. Silenced Transgelin (shTAGLN‑2.15) cells were constructed, and the cell viability was analyzed by the CCK8 assay after treatment with JS‑K. There were 182 diferentially expressed proteins in JS‑K treated‑HepG2.2.15 cells; 73 proteins were up‑regulated and 109 proteins were down‑regulated. These proteins were categorized according to GO classifcation. KEGG enrichment analysis showed that Endocytosis, Phagosome and Proteoglycans were the most signifcant pathways. RT‑PCR confrmed that the expression levels of TAGLN, IGFBP1, SMTN, SERPINE1, ANXA3, TMSB10, LGALS1 and KRT19 were signifcantly up‑regulated, and the expression levels of C5, RBP4, CHKA, SIRT5 and TRIM14 were signifcantly down‑regulated in JS‑K treated‑HepG2.2.15 cells. Western blotting confrmed the increased levels of USP13 and TAGLN proteins in JS‑K treated‑HepG2.2.15 cells. Molecular docking revealed the binding of JS‑K to TAGLN and shTAGLN‑2.15 cells were resistant to JS‑K cytotoxicity, suggesting that TAGLN could be an important target in JS‑K anti‑HBV‑positive liver cancer cells. These proteomic fndings could shed new insights into mechanisms underlying the efect of JS‑K against HBV‑related HCC. Hepatitis B virus (HBV) infection is associated with an increased risk of hepatic cirrhosis, hepatic decompensa- tion, and hepatocellular carcinoma (HCC). HCC is one of the leading malignant deaths worldwide. Over 350 million people are chronically infected with HBV who are at greater risk of HCC compared with uninfected people1. Terefore, it is very important to fnd efective drugs to kill HBV-positive HCC. JS-K (O2-(2, 4-dinitrophenyl) 1-[(4-ethoxycarbonyl) piperazin-1-yl] diazen -1-ium-1, 2-diolate) belongs to the diazeniumdiolate class of prodrug designed to be activated for nitric oxide (NO) release by glutathione S-transferase (GST)2. As a novel anticancer drug, JS-K is efective against a variety of cancer cells including human myeloid leukemia cells3, human multiple myeloma cell lines4, renal cancer cells, prostate cancer cells, brain cancer cells, etc.5. In addition, studies from ours and other research groups found that JS-K was also efec- tive against human HCC6,7. Our previous study demonstrated that JS-K decreased the expression of HBsAg and HBeAg in HepG2.2.15 cells8 and was efective against HBV-positive HCC HepG2.2.15 cells and its mechanism is related with DNA damage and apoptosis9. To better understand the mechanisms of JS-K on HepG2.2.15 cells, we utilized recent advances in proteomics technology and bioinformatics to explore diferentially expressed proteins (DEPs), and protein profle associ- ated with HBV-modulated DNA methylation 10. In the current study, we used stable iTRAQ to identify DEPs 1Key Laboratory of Infectious Disease and Biosafety, Provincial Department of Education, Guizhou, Zunyi Medical University, Zunyi 563000, Guizhou, China. 2Department of Microbiology, Zunyi Medical University, Zunyi 563000, Guizhou, China. 3Key Lab for Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine, Zunyi Medical University, Zunyi 563000, Guizhou, China. 4These authors contributed equally: Zhengyun Liu and Yan Xu. *email: wanghuan928@163.com Scientifc Reports | (2021) 11:10381 | https://doi.org/10.1038/s41598-021-90001-3 1 Vol.:(0123456789) www.nature.com/scientificreports/ in HepG2.2.15 cells treated with or without JS-K. Te research will provide novel insights into the molecular mechanisms involved in the anti-HBV and anti-HBV-positive HCC activity of JS-K. Materials and methods Reagents. JS-K was purchased from Santa Cruz Biotechnology (California, USA); Dulbecco’s Modifed Eagle’s Medium/Nutrient Mixture F-12 Ham (DMEM/F12) was obtained from Hyclone (Utah, USA); Fetal bovine serum (FBS) was purchased from Gibco (California, USA); USP13 and TAGLN antibodies were pur- chased from Santa Cruz Biotechnology (California, USA); β-actin antibody was purchased from BIOSS (Beijing, China); ECL reagents were purchased from Solarbi (Beijing, China); PrimeScript RT reagent Kit and TB Green Premix Ex Taq were purchased from Takara (Tokyo, Japan). CCK8 reagent was purchased from Living (Beijing, China). Cell culture and treatment. Te HBV-positive human hepatoma cell line HepG2.2.15 cells, shNC-2.15 cells and shTAGLN1#-2.15 cells (preserved in Key Laboratory of Infectious Disease & Biosafety, Provincial Department of Education, Guizhou, Zunyi Medical University) were maintained with DMEM/F12 medium containing 10% FBS, 0.5 mg/ml G418, 100 μg/mLstreptomycin and 100 IU/mL penicillin at 5% CO2, 37 °C. Te medium was changed two times per week. For iTRAQ-based quantitative proteomics analysis, HepG2.2.15 cells were treated 24 h with 10 µM JS-K. Te experiments were repeated with at least three diferent biological rep- licates. Cell pellets were washed with ice-cold PBS, instantly frozen and stored at − 80 °C until further analysis. Protein preparation. For each sample, 6300 μg of total proteins were diluted in 4% SDS, 100 mM Tris–HCl (pH 8.0), and 100 mM DTT and heated at 100ºC for 5 min. Each sample was then cooled to RT(room tempera- ture) and loaded onto an ultrafltration flter (30 kDa cutof, Sartorius, Germany) containing 200 μL of UA bufer (8 M urea, 150 mM Tris–HCl, pH 8.0) followed by centrifugation at 14,000×g for 30 min and an additional washing step with 200 μL of UA bufer. 100 µL of 50 mM iodoacetamide in UA bufer was subsequently added to the flter to block the reduced cysteine residues, and the samples were then incubated for 30 min at RT in the dark followed by centrifugation at 14,000×g for 30 min. Te flters were washed with 100 μL of UA bufer and centrifuged at 14,000×g for 20 min, and 100 µL dissolution bufer was added to elute protein. Te procedure was repeated twice. Te protein suspensions were then digested with 40 μL of trypsin (Promega, Madison, WI, USA) bufer (2 μg trypsin in 40μL dissolution bufer) at 37 °C for 16–18 h. Finally, the flter unit was transferred to a new tube and centrifuged at 14,000×g for 30 min. Te resulting peptides were collected as a fltrate, and the peptide concentration was determined at absorbance of 280 nm11. iTRAQ labeling and high‑pH reversed‑phase fractionation. iTRAQ labeling was performed accord- ing to the manufacturer’s instructions (Applied Biosystems). Briefy, the peptide mixtures were reconstituted with 30 μL of iTRAQ dissolution bufer. Te label method of every sample (100 μg) used iTRAQ Reagent-8plex Multiplex Kit (AB SCIEX) (JS-K 0-1, 113; JS-K 0-2, 114; JS-K 0-3, 115; JS-K 10-1, 116; JS-K 10-2, 117; JS-K 10-3, 118). Te labeling solution reaction was then incubated at room temperature for 1 h prior to further analysis. Te six labeled samples were pooled into one sample and dried in a vacuum centrifuge at room temperature. Te iTRAQ-labeled peptides were subjected to High-pH Reversed-Phase Fractionation in 1100 Series HPLC Value System (Agilent) equipped with a Gemini-NX (Phenomenex, 00F-4453-E0) column (4.6 × 150 mm, 3 µm, 110 Å)12. Te peptides were eluted at a fow rate of 1 mL/min with Bufer A (10 mM ammonium acetate, pH 10.0). Te following gradients were applied to perform separation: 100% Bufer A for 30 min, 0–5% Bufer B (10 mM ammonium acetate, 90% v/v ACN, pH 3.0) for 5 min, 5–35% Bufer B for 30 min, 35–70% Bufer B for 10 min, 70–100% Bufer B for 5 min, 100% Bufer B for 15 min, and fnally 100% Bufer A for 15 min. Te elu- tion process was monitored by measuring absorbance at 214 nm, and fractions were collected every 1 min. Te collected fractions (approximately 50) were fnally combined into ffeen pools. Each fraction was concentrated via vacuum centrifugation and reconstituted in 40 μL of 0.1% v/v trifuoroacetic acid. All samples were stored at – 80 °C until LC–MS/MS analysis13. LC–MS/MS analysis. Te iTRAQ-labeled samples were analyzed using Easy-nLC nanofow HPLC system connected to Orbitrap Elite mass spectrometer (Termo Fisher Scientifc, San Jose, CA, USA). A total of 1 μg of each sample was loaded onto Termo Scientifc EASY column using an autosampler at a fow rate of 150 nL/ min. Te sequential separation of peptides on Termo Scientifc EASY trap column and analytical column was accomplished using a segmented 1 h gradient from Solvent A (0.1% formic acid in water) to 35% Solvent B (0.1% formic acid in 100% ACN) for 50 min, followed by 35–90% Solvent B for 3 min and then 90% Solvent B for 7 min. Te column was re-equilibrated to its initial highly aqueous solvent composition before each analy- sis. Te mass spectrometer was operated in positive ion mode, and MS spectra were acquired over a range of 300–2000 m/z. Te resolving powers of the MS scan and MS/MS scan at 200 m/z for the Orbitrap Elite were set as 60,000 and 15,000, respectively13. Protein identifcation and quantifcation.
Recommended publications
  • Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins
    International Journal of Molecular Sciences Article Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins M. Quadir Siddiqui 1,† , Maulik D. Badmalia 1,† and Trushar R. Patel 1,2,3,* 1 Alberta RNA Research and Training Institute, Department of Chemistry and Biochemistry, University of Lethbridge, 4401 University Drive, Lethbridge, AB T1K 3M4, Canada; quadir.siddiqui@uleth.ca (M.Q.S.); maulik.badmalia@uleth.ca (M.D.B.) 2 Department of Microbiology, Immunology and Infectious Disease, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive, Calgary, AB T2N 4N1, Canada 3 Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada * Correspondence: trushar.patel@uleth.ca † These authors contributed equally to the work. Abstract: Members of the human Zyxin family are LIM domain-containing proteins that perform critical cellular functions and are indispensable for cellular integrity. Despite their importance, not much is known about their structure, functions, interactions and dynamics. To provide insights into these, we used a set of in-silico tools and databases and analyzed their amino acid sequence, phylogeny, post-translational modifications, structure-dynamics, molecular interactions, and func- tions. Our analysis revealed that zyxin members are ohnologs. Presence of a conserved nuclear export signal composed of LxxLxL/LxxxLxL consensus sequence, as well as a possible nuclear localization signal, suggesting that Zyxin family members may have nuclear and cytoplasmic roles. The molecular modeling and structural analysis indicated that Zyxin family LIM domains share Citation: Siddiqui, M.Q.; Badmalia, similarities with transcriptional regulators and have positively charged electrostatic patches, which M.D.; Patel, T.R.
    [Show full text]
  • The Future of Dermatopathology
    Modern Pathology (2006) 19, S155–S163 & 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org The future of dermatopathology A Neil Crowson Departments of Dermatology, Pathology, and Surgery, University of Oklahoma and Regional Medical Laboratory, St John Medical Center, Tulsa, OK, USA Of the major issues that dermatopathology will face in the immediate future, two powerful challenges loom large. The first is the application of novel nondestructive imaging technologies to in vivo diagnosis in humans. The second is the application of molecular technologies to a diagnostic arena which formerly belonged exclusively to the light microscopist. The first to be considered in this context is the application of near infrared spectroscopy to the noninvasive in vivo diagnosis of neoplastic skin disease. The second will be a discussion of application, methodology and the current state of the art in microarray technologies as they apply to neoplastic dermatopathology and, in particular, the diagnosis and prognostication of melanoma. Modern Pathology (2006) 19, S155–S163. doi:10.1038/modpathol.3800513 Keywords: in vivo microscope; tissue microarray; basal cell carcinoma; infrared spectroscopy Noninvasive assessment of skin lesions keratoses and squamous cell carcinomata in vitro. by near infrared (IR) spectroscopy Melanocytic nevi could be subdivided into banal vs dysplastic nevi based upon their spectral differences In the late 1990s, working with Dr Laura McIntosh and melanomas could be separately recognized as and colleagues at the National Research Council of well. Furthermore, the different types of lesion were Canada, the University of Manitoba, Central Medical shown to have distinct mid-IR signatures when Laboratories and the Misericordia General Hospital compared to adjacent normal epidermal and dermal in Winnipeg, Canada, we designed and patented a compartments.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • The Genetics of Bipolar Disorder
    Molecular Psychiatry (2008) 13, 742–771 & 2008 Nature Publishing Group All rights reserved 1359-4184/08 $30.00 www.nature.com/mp FEATURE REVIEW The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions A Serretti and L Mandelli Institute of Psychiatry, University of Bologna, Bologna, Italy Bipolar disorder (BP) is a complex disorder caused by a number of liability genes interacting with the environment. In recent years, a large number of linkage and association studies have been conducted producing an extremely large number of findings often not replicated or partially replicated. Further, results from linkage and association studies are not always easily comparable. Unfortunately, at present a comprehensive coverage of available evidence is still lacking. In the present paper, we summarized results obtained from both linkage and association studies in BP. Further, we indicated new potential interesting genes, located in genome ‘hot regions’ for BP and being expressed in the brain. We reviewed published studies on the subject till December 2007. We precisely localized regions where positive linkage has been found, by the NCBI Map viewer (http://www.ncbi.nlm.nih.gov/mapview/); further, we identified genes located in interesting areas and expressed in the brain, by the Entrez gene, Unigene databases (http://www.ncbi.nlm.nih.gov/entrez/) and Human Protein Reference Database (http://www.hprd.org); these genes could be of interest in future investigations. The review of association studies gave interesting results, as a number of genes seem to be definitively involved in BP, such as SLC6A4, TPH2, DRD4, SLC6A3, DAOA, DTNBP1, NRG1, DISC1 and BDNF.
    [Show full text]
  • A Systems Genetics Approach to Revealing the Pdgfb Molecular Network of the Retina
    Molecular Vision 2020; 26:459-471 <http://www.molvis.org/molvis/v26/459> © 2020 Molecular Vision Received 19 November 2019 | Accepted 17 June 2020 | Published 19 June 2020 A systems genetics approach to revealing the Pdgfb molecular network of the retina Shasha Li,1,2 Fuyi Xu,2 Lin Liu,1 Rong Ju,3 Jonas Bergquist,1,4 Qing Yin Zheng,5,6 Jia Mi,1 Lu Lu,2 Xuri Li,3 Geng Tian1 (The first two authors contributed equally to this work.) 1Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, China; 2Department of Genetics, Genomics and informatics, University of Tennessee Health Science Center, Memphis, TN; 3State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China; 4Analytical Chemistry and Neurochemistry, Department of Chemistry-BMC, Uppsala University, Uppsala, Sweden; 5Transformative Otology and Neuroscience Center, Case Western Reserve University School of Medicine, Cleveland, OH; 6Departments of Otolaryngology, Case Western Reserve University School of Medicine, Cleveland, OH. Purpose: Platelet-derived growth factor (PDGF) signaling is well known to be involved in vascular retinopathies. Among the PDGF family, the subunit B (PDGFB) protein is considered a promising therapeutic target. This study aimed to identify the genes and potential pathways through which PDGFB affects retinal phenotypes by using a systems genetics approach. Methods: Gene expression data had been previously generated in a laboratory for the retinas of 75 C57BL/6J(B6) X DBA/2J (BXD) recombinant inbred (RI) strains. Using this data, the genetic correlation method was used to identify genes correlated to Pdgfb. A correlation between intraocular pressure (IOP) and Pdgfb was calculated based on the Pearson correlation coefficient.
    [Show full text]
  • Deer Thymosin Beta 10 Functions As a Novel Factor for Angiogenesis And
    Zhang et al. Stem Cell Research & Therapy (2018) 9:166 https://doi.org/10.1186/s13287-018-0917-y RESEARCH Open Access Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration Wei Zhang1,2†, Wenhui Chu1,2†, Qingxiu Liu1,2†, Dawn Coates3, Yudong Shang1,2 and Chunyi Li1,2* Abstract Background: Deer antlers are the only known mammalian organ with vascularized cartilage that can completely regenerate. Antlers are of real significance as a model of mammalian stem cell-based regeneration with particular relevance to the fields of chondrogenesis, angiogenesis, and regenerative medicine. Recent research found that thymosin beta 10 (TMSB10) is highly expressed in the growth centers of growing antlers. The present study reports here the expression, functions, and molecular interactions of deer TMSB10. Methods: The TMSB10 expression level in both tissue and cells in the antler growth center was measured. The effects of both exogenous (synthetic protein) and endogenous deer TMSB10 (lentivirus-based overexpression) on antlerogenic periosteal cells (APCs; nonactivated antler stem cells with no basal expression of TMSB10) and human umbilical vein endothelial cells (HUVECs; endothelial cells with no basal expression of TMSB10) were evaluated to determine whether TMSB10 functions on chondrogenesis and angiogenesis. Differences in deer and human TMSB10 in angiogenesis and molecular structure were determined using animal models and molecular dynamics simulation, respectively. The molecular mechanisms underlying deer TMSB10 in promoting angiogenesis were also explored. Results: Deer TMSB10 was identified as a novel proangiogenic factor both in vitro and in vivo. Immunohistochemistry revealed that TMSB10 was widely expressed in the antler growth center in situ, with the highest expression in the reserve mesenchyme, precartilage, and transitional zones.
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • RNA Sequencing Reveals the Alteration of the Expression of Novel Genes in Ethanol-Treated Embryoid Bodies
    RESEARCH ARTICLE RNA Sequencing Reveals the Alteration of the Expression of Novel Genes in Ethanol-Treated Embryoid Bodies Chanchal Mandal1, Sun Hwa Kim1, Jin Choul Chai1, Seon Mi Oh1, Young Seek Lee1, Kyoung Hwa Jung2*, Young Gyu Chai1,3* 1 Department of Molecular and Life Science, Hanyang University, Ansan, Republic of Korea, 2 Institute of Natural Science and Technology, Hanyang University, Ansan, Republic of Korea, 3 Department of Bionanotechnology, Hanyang University, Seoul, Republic of Korea * ygchai@hanyang.ac.kr (YGC); khjung2@gmail.com (KHJ) Abstract Fetal alcohol spectrum disorder is a collective term representing fetal abnormalities associ- OPEN ACCESS ated with maternal alcohol consumption. Prenatal alcohol exposure and related anomalies are well characterized, but the molecular mechanism behind this phenomenon is not well Citation: Mandal C, Kim SH, Chai JC, Oh SM, Lee characterized. In this present study, our aim is to profile important genes that regulate cellu- YS, Jung KH, et al. (2016) RNA Sequencing Reveals the Alteration of the Expression of Novel Genes in lar development during fetal development. Human embryonic carcinoma cells (NCCIT) are Ethanol-Treated Embryoid Bodies. PLoS ONE 11(3): cultured to form embryoid bodies and then treated in the presence and absence of ethanol e0149976. doi:10.1371/journal.pone.0149976 (50 mM). We employed RNA sequencing to profile differentially expressed genes in the eth- Editor: Shihui Yang, National Renewable Energy anol-treated embryoid bodies from NCCIT vs. EB, NCCIT vs. EB+EtOH and EB vs. EB Lab, UNITED STATES +EtOH data sets. A total of 632, 205 and 517 differentially expressed genes were identified Received: July 13, 2015 from NCCIT vs.
    [Show full text]
  • The Human Gene Connectome As a Map of Short Cuts for Morbid Allele Discovery
    The human gene connectome as a map of short cuts for morbid allele discovery Yuval Itana,1, Shen-Ying Zhanga,b, Guillaume Vogta,b, Avinash Abhyankara, Melina Hermana, Patrick Nitschkec, Dror Friedd, Lluis Quintana-Murcie, Laurent Abela,b, and Jean-Laurent Casanovaa,b,f aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Paris Descartes University, Institut National de la Santé et de la Recherche Médicale U980, Necker Medical School, 75015 Paris, France; cPlateforme Bioinformatique, Université Paris Descartes, 75116 Paris, France; dDepartment of Computer Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel; eUnit of Human Evolutionary Genetics, Centre National de la Recherche Scientifique, Unité de Recherche Associée 3012, Institut Pasteur, F-75015 Paris, France; and fPediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, 75015 Paris, France Edited* by Bruce Beutler, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 15, 2013 (received for review October 19, 2012) High-throughput genomic data reveal thousands of gene variants to detect a single mutated gene, with the other polymorphic genes per patient, and it is often difficult to determine which of these being of less interest. This goes some way to explaining why, variants underlies disease in a given individual. However, at the despite the abundance of NGS data, the discovery of disease- population level, there may be some degree of phenotypic homo- causing alleles from such data remains somewhat limited. geneity, with alterations of specific physiological pathways under- We developed the human gene connectome (HGC) to over- come this problem.
    [Show full text]
  • Dissecting Heterogeneous Cell Populations Across Drug and Disease Conditions with Popalign
    Dissecting heterogeneous cell populations across drug and disease conditions with PopAlign Sisi Chena,b,1 , Paul Rivauda,b , Jong H. Parka,b, Tiffany Tsoua,b , Emeric Charlesc, John R. Haliburtond, Flavia Pichiorrie, and Matt Thomsona,b,1 aDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125; bBeckman Center for Single-Cell Profiling and Engineering, California Institute of Technology, Pasadena, CA 91125; cDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720; dAugmenta Bioworks Inc., Menlo Park, CA 94025; and eDepartment of Hematologic Malignancies Translational Science, City of Hope, Monrovia, CA 91016 Edited by Jonathan S. Weissman, University of California, San Francisco, CA, and approved September 25, 2020 (received for review March 31, 2020) Single-cell measurement techniques can now probe gene expres- The key conceptual advance underlying PopAlign is repre- sion in heterogeneous cell populations from the human body sentational: we model the distribution of gene-expression states across a range of environmental and physiological conditions. within a heterogeneous cell population using a probabilistic However, new mathematical and computational methods are mixture model that we infer from single-cell data. PopAlign required to represent and analyze gene-expression changes that identifies and represents subpopulations of cells as indepen- occur in complex mixtures of single cells as they respond to sig- dent Gaussian densities within a reduced
    [Show full text]
  • Chemical Proteomics Reveal CD147 As a Functional Target of Pseudolaric
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2017 Electronic Supplementary Material (ESI) for Chemical proteomics reveal CD147 as a functional target of pseudolaric acid B in human cancer cells Yiqing Zhou,a Zhengao Di,a Xiaoming Li,bc Yuanhong Shan,d Weichao Li,a Haibing Zhang,b and Youli Xiao*acd aCAS Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China bInstitute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China cUniversity of Chinese Academy of Sciences, Beijing, 100039, China dCore Facility Centre of the Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China 1 Table of Contents 1. Chemistry Pages 3-5 1.1 Synthesis of PAB-Dayne Page 3 Fig. S1 1H-NMR and 13C-NMR data of PAB-Dayne Page 3 1.2 Synthesis of Dead-Dayne Page 4 Fig. S2 1H-NMR and 13C-NMR data of Dead-Dayne Page 5 2. Biological experiments Pages 6-15 2.1 Labeling of purified porcine brain tubulin Page 6 Fig. S3 Dose-dependent labeling of tubulin by PAB-Dayne. Page 6 2.2 Cell proliferation assay Page 6 Table S1 IC50 values of PAB and probes towards HeLa cells. Page 7 2.3 Gel-based AfBPP in HeLa cells Page 7 Fig. S4 Full imaging of gels in Figure 2A. Page 7 2.4 Microscopy Page 7 2.5 Mass spectrometry-based AfBPP in HeLa cells Page 8 2.6 Target validation by pull-down and western blot Page 9 2.7 Labeling of recombinant CD147/CD98 proteins Page 9 2.8 Disruption of CD147 oligomerization by PAB Page 10 2.9 Binding site identification Page 10 Fig.
    [Show full text]
  • Robust Hypergraph Regularized Non-Negative Matrix Factorization for Sample Clustering and Feature Selection in Multi-View Gene E
    Yu et al. Human Genomics 2019, 13(Suppl 1):46 https://doi.org/10.1186/s40246-019-0222-6 RESEARCH Open Access Robust hypergraph regularized non- negative matrix factorization for sample clustering and feature selection in multi- view gene expression data Na Yu1, Ying-Lian Gao2, Jin-Xing Liu1*, Juan Wang1* and Junliang Shang1 From IEEE International Conference on Bioinformatics and Biomedicine 2018 Madrid, Spain. 3-6 December 2018 Abstract Background: As one of the most popular data representation methods, non-negative matrix decomposition (NMF) has been widely concerned in the tasks of clustering and feature selection. However, most of the previously proposed NMF-based methods do not adequately explore the hidden geometrical structure in the data. At the same time, noise and outliers are inevitably present in the data. Results: To alleviate these problems, we present a novel NMF framework named robust hypergraph regularized non-negative matrix factorization (RHNMF). In particular, the hypergraph Laplacian regularization is imposed to capture the geometric information of original data. Unlike graph Laplacian regularization which captures the relationship between pairwise sample points, it captures the high-order relationship among more sample points. Moreover, the robustness of the RHNMF is enhanced by using the L2,1-norm constraint when estimating the residual. This is because the L2,1-norm is insensitive to noise and outliers. Conclusions: Clustering and common abnormal expression gene (com-abnormal expression gene) selection are conducted to test the validity of the RHNMF model. Extensive experimental results on multi-view datasets reveal that our proposed model outperforms other state-of-the-art methods.
    [Show full text]